Immuneering Corp (IMRX)
Immuneering Corp (IMRX)
| Balance Sheets | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 47,321,566 | 227,563,077 | 26,355,498 | |
| Marketable securities | 109,372,057 | NaN | NaN | |
| Prepaids and other current assets | 4,715,535 | 1,538,752 | 1,369,928 | |
| Total current assets | 161,409,158 | 229,101,829 | 27,725,426 | |
| Marketable securities, non-current | 41,950,745 | NaN | NaN | |
| Property and equipment, net | 937,008 | 892,553 | 964,138 | |
| Goodwill | 6,690,431 | 6,690,431 | 6,690,431 | |
| Intangible asset, net | 313,830 | 328,463 | 335,780 | |
| Right-of-use assets | 3,230,489 | 3,411,693 | 3,498,967 | |
| Other assets | 278,129 | 631,297 | 841,726 | |
| Total assets | 214,809,790 | 241,056,266 | 40,056,468 | |
| Accounts payable | 1,453,158 | 1,600,274 | 2,395,203 | |
| Accrued expenses | 3,064,066 | 7,483,142 | 4,514,960 | |
| Other liabilities | 44,191 | 80,089 | 209,708 | |
| Lease liabilities | 412,835 | 381,760 | 366,959 | |
| Total current liabilities | 4,974,250 | 9,545,265 | 7,486,830 | |
| Lease liabilities, net of current portion | 3,317,369 | 3,534,569 | 3,633,601 | |
| Total liabilities | 8,291,619 | 13,079,834 | 11,120,431 | |
| Common stock-Common Class A | 64,689 | 63,483 | 35,987 | |
| Common stock-Common Class B | 0 | 0 | 0 | |
| Additional paid-in capital | 500,475,466 | 496,653,023 | 282,675,249 | |
| Accumulated other comprehensive income (loss) | -241,005 | NaN | NaN | |
| Accumulated deficit | -293,780,979 | -268,740,074 | -253,775,199 | |
| Total stockholders' equity | 206,518,171 | 227,976,432 | 28,936,037 | |
| Total liabilities and stockholders' equity | 214,809,790 | 241,056,266 | 40,056,468 | |